Table 1A. Detailed characteristics of major hallmarks of cellular senescence of the individual donors HDF161, HDF76 and HDF85 each senescent and quiescent control after 7 (D7) days post last H2O2 application.
1 week recovery (D7) | |||||||||||||
Donor | Total apoptotic cells (Annexin + PI positive) [%] | BrdU positive cells [%] | Sub-G1 peak (PI staining) [%] | CDKN1A mRNA expression norm.FC | SA-βGal positive cells [%] | ||||||||
Q | S | + | Q | S | Y | Q | S | Q | S | Y | Y | S | |
HDF161 | 1.7 | 4.3 | 49 | 15 | 5 | 55 | 2.5 | 3.9 | 0.6 | 1.1 | 0.9 | 16.1 | 50 |
HDF85 | 1.1 | 4.1 | 12 | 14 | 2.8 | 35 | 0.7 | 4.8 | 1.3 | 1.7 | 1.0 | 13 | 74 |
HDF76 | 1.5 | 4.7 | 40 | 15 | 8 | 48 | 1.2 | 3.3 | 1.2 | 1.9 | 0.8 | 13.8 | 49 |
Abbreviations: Q = quiescent control, S = stress induced premature senescent, + = positive control – Staurosporin 300nM overnight, Y = proliferating control.